FDA Approved: SODIUM POLYSTYRENE SULFONATE — Supplemental Application (CMP Pharma, Inc.)

View source ↗

Summary

FDA approves CMP Pharma, Inc.'s supplemental application for Sodium Polystyrene Sulfonate under ANDA087859.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperkalemia

Drugs mentioned

• Sodium polystyrene sulfonate (Sodium polystyrene sulfonate)

Snippet

SUPPL AP for SODIUM POLYSTYRENE SULFONATE (SODIUM POLYSTYRENE SULFONATE)